Acquired chemotherapeutic drug resistance in colorectal cancer is regulated by epithelial-to-mesenchymal transition and altered cellular pathways

被引:0
|
作者
Gangoda, Lahiru
Mathew, Nidhi
Liem, Michael
Keertikumar, Shiva
Ang, Ching-Seng
Mariadason, John
Mathivanan, Suresh
机构
关键词
D O I
10.1158/1538-7445.AM2017-5880
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5880
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and Epithelial-to-Mesenchymal Transition Pathways
    Kandasamy, Thirukumaran
    Sarkar, Shilpi
    Ghosh, Siddhartha Sankar
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024,
  • [2] Oxaliplatin resistance in colorectal cancer cells induces epithelial-to-mesenchymal transition
    Yang, AD
    Fan, F
    Camp, ER
    Somcio, RJ
    Gray, MJ
    Liu, W
    Ellis, LM
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 6 - 6
  • [3] Commentary on "Epithelial-to-Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer"
    Beach, Jessica A.
    Bowtell, David D. L.
    CANCER RESEARCH, 2016, 76 (24) : 7075 - 7077
  • [4] Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
    Zafari, Nima
    Velayati, Mahla
    Nassiri, Mohammadreza
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (28) : 2298 - 2311
  • [5] Platelet-derived RANKL in epithelial-to-mesenchymal transition and resistance of cancer cells to chemotherapeutic treatment
    Maurer, S.
    Hinterleitner, C.
    Kanz, L.
    Kopp, H. -G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 93 - 93
  • [6] Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
    Dekervel, Jeroen
    Bulle, Ashenafi
    Windmolders, Petra
    Lambrechts, Diether
    Van Cutsem, Eric
    Verslype, Chris
    van Pelt, Jos
    TRANSLATIONAL ONCOLOGY, 2017, 10 (01): : 59 - 69
  • [7] Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
    James W. Antoon
    Rongye Lai
    Amanda P. Struckhoff
    Ashley M. Nitschke
    Steven Elliott
    Elizabeth C. Martin
    Lyndsay V. Rhodes
    Nam Seung Yoon
    Virgilio A. Salvo
    Bin Shan
    Barbara S. Beckman
    Kenneth P. Nephew
    Matthew E. Burow
    Scientific Reports, 2
  • [8] Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
    Antoon, James W.
    Lai, Rongye
    Struckhoff, Amanda P.
    Nitschke, Ashley M.
    Elliott, Steven
    Martin, Elizabeth C.
    Rhodes, Lyndsay V.
    Yoon, Nam Seung
    Salvo, Virgilio A.
    Shan, Bin
    Beckman, Barbara S.
    Nephew, Kenneth P.
    Burow, Matthew E.
    SCIENTIFIC REPORTS, 2012, 2
  • [9] Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
    Yang, Anthony D.
    Fan, Fan
    Camp, E. Ramsay
    van Buren, George
    Liu, Wenbiao
    Somcio, Ray
    Gray, Michael J.
    Cheng, Haiyun
    Hoff, Paulo M.
    Ellis, Lee M.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4147 - 4153
  • [10] Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
    Marijon, Helene
    Dokmak, Safi
    Paradis, Valerie
    Zappa, Magaly
    Bieche, Ivan
    Bouattour, Mohamed
    Raymond, Eric
    Faivre, Sandrine
    JOURNAL OF HEPATOLOGY, 2011, 54 (05) : 1073 - 1078